GRIO


FARDELLONE

Pr Patrice FARDELLONE

Comité scientifique du GRIO


Présentation > Les membres du Comité Directeur > Pr Patrice FARDELLONE > Publications

PUBLICATIONS RÉCENTES


Ganry O, Lapôtre-Ledoux B, Fardellone P, Dubreuil A. Bone mass density, subsequent risk of colon cancer and survival in postmenopausal women. Eur J Epidemiol. 2008 May 10. [Epub ahead of print]

Sturdee DW, Archer DF, Rakov V, Lang E; CHOICE Study Investigators. Ultra-low-dose continuous combined estradiol and norethisterone acetate: improved bleeding profile in postmenopausal women. Climacteric. 2008;11(1):63-73

Lespessailles E, Gadois C, Kousignian I, Neveu JP, Fardellone P, Kolta S, Roux C, Do-Huu JP, Benhamou CL. Clinical interest of bone texture analysis in osteoporosis: a case control multicenter study. Osteoporos Int. 2008 Jan 15. [Epub ahead of print]

Boonen S, Marin F, Obermayer-Pietsch B, Simões ME, Barker C, Glass EV, Hadji P, Lyritis G, Oertel H, Nickelsen T, McCloskey EV; EUROFORS Investigators. Effects of previous antiresorptive therapy on the bone mineral density response to two years of teriparatide treatment in postmenopausal women with osteoporosis. J Clin Endocrinol Metab. 2008;93(3):852-60. Epub 2007 Dec 26

Roux CH, Saraux A, Mazieres B, Pouchot J, Morvan J, Fautrel B, Testa J, Fardellone P, Rat AC, Coste J, Guillemin F, Euller-Ziegler L. Screening for hip and knee osteoarthritis in the general population: predictive value of a questionnaire and prevalence estimates. Ann Rheum Dis. 2007 Dec 12. [Epub ahead of print]

Hadji P, Minne H, Pfeifer M, Bourgeois P, Fardellone P, Licata A, Devas V, Masanauskaite D, Barrett-Connor E. Treatment preference for monthly oral ibandronate and weekly oral alendronate in women with postmenopausal osteoporosis: A randomized, crossover study (BALTO II). Joint Bone Spine. 2008;75(3):303-10. Epub 2007 Oct 22

Cotté FE, Cortet B, Lafuma A, Avouac B, Hasnaoui AE, Fardellone P, Pouchain D, Roux C, Gaudin AF. A model of the public health impact of improved treatment persistence in post-menopausal osteoporosis in France. Joint Bone Spine. 2008;75(2):201-8. Epub 2007 Aug 31

Cooper C, Jakob F, Chinn C, Martin-Mola E, Fardellone P, Adami S, Thalassinos NC, Melo-Gomes J, Torgerson D, Gibson A, Marin F. Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO). Osteoporos Int. 2008;19(4):493-501. Epub 2007 Oct 30

Combe B, Benessiano J, Berenbaum F, Cantagrel A, Daurès JP, Dougados M, Fardellone P, Fautrel B, Flipo RM, Goupille P, Guillemin F, Le Loet X, Logeart I, Mariette X, Meyer O, Ravaud P, Rincheval N, Saraux A, Schaeverbeke T, Sibilia J. The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients. Joint Bone Spine. 2007;74(5):440-5. Epub 2007 Jul 26

Bruyere O, Roux C, Detilleux J, Slosman DO, Spector TD, Fardellone P, Brixen K, Devogelaer JP, Diaz-Curiel M, Albanese C, Kaufman JM, Pors-Nielsen S, Reginster JY. Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate. J Clin Endocrinol Metab. 2007;92(8):3076-81. Epub 2007 Jun 12

Clavel G, Bessis N, Lemeiter D, Fardellone P, Mejjad O, Ménard JF, Pouplin S, Boumier P, Vittecoq O, Le Loët X, Boissier MC. Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction. Clin Immunol. 2007;124(2):158-64. Epub 2007 Jun 8

Bombardieri S, Ruiz AA, Fardellone P, Geusens P, McKenna F, Unnebrink K, Oezer U, Kary S, Kupper H, Burmester GR; Research in Active Rheumatoid Arthritis (ReAct) Study Group. Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practice. Rheumatology (Oxford). 2007 Jul;46(7):1191-9. Epub 2007 May 15

Bonjour JP, Chevalley T, Fardellone P. Calcium intake and vitamin D metabolism and action, in healthy conditions and in prostate cancer. Br J Nutr. 2007;97(4):611-6

Grados F, Lescure FX, Senneville E, Flipo RM, Schmit JL, Fardellone P. Suggestions for managing pyogenic (non-tuberculous) discitis in adults. Joint Bone Spine. 2007;74(2):133-9. Epub 2007 Feb 2. Review

Roux CH, Saraux A, Le Bihan E, Fardellone P, Guggenbuhl P, Fautrel B, Masson C, Chary-Valckenaere I, Cantagrel A, Juvin R, Flipo RM, Euller-Ziegler L, Coste J, Guillemin F. Rheumatoid arthritis and spondyloarthropathies: geographical variations in prevalence in France. J Rheumatol. 2007;34(1):117-22. Epub 2006 Nov 15

Jakob F, Marín F, Martín-Mola E, Torgerson D, Fardellone P, Adami S, Thalassinos NC, Sykes D, Melo-Gomes J, Chinn C, Nicholson T, Cooper C. Characterization of patients with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO). QJM. 2006;99(8):531-43. Epub 2006 Jul 22

Roux C, Reginster JY, Fechtenbaum J, Kolta S, Sawicki A, Tulassay Z, Luisetto G, Padrino JM, Doyle D, Prince R, Fardellone P, Sorensen OH, Meunier PJ. Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors. J Bone Miner Res. 2006;21(4):536-42. Epub 2006 Apr 5

Brazier M, Grados F, Kamel S, Mathieu M, Morel A, Maamer M, Sebert JL, Fardellone P. Clinical and laboratory safety of one year's use of a combination calcium + vitamin D tablet in ambulatory elderly women with vitamin D insufficiency: results of a multicenter, randomized, double-blind, placebo-controlled study. Clin Ther. 2005;27(12):1885-93

Clavel G, Grados F, Lefauveau P, Fardellone P. Osteoarticular side effects of BCG therapy. Joint Bone Spine. 2006;73(1):24-8. Epub 2005 Mar 24. Review

Maravic M, Le Bihan C, Landais P, Fardellone P. Incidence and cost of osteoporotic fractures in France during 2001. A methodological approach by the national hospital database. Osteoporos Int. 2005;16(12):1475-80. Epub 2005 Oct 11

Goëb V, Dieudé P, Vittecoq O, Mejjad O, Ménard JF, Thomas M, Gilbert D, Boumier P, Pouplin S, Daragon A, Fardellone P, Tron F, Cornélis F, Le Loët X. Association between the TNFRII 196R allele and diagnosis of rheumatoid arthritis. Arthritis Res Ther. 2005;7(5):R1056-62. Epub 2005 Jun 29

Saraux A, Guillemin F, Guggenbuhl P, Roux CH, Fardellone P, Le Bihan E, Cantagrel A, Chary-Valckenaere I, Euller-Ziegler L, Flipo RM, Juvin R, Behier JM, Fautrel B, Masson C, Coste J. Prevalence of spondyloarthropathies in France: 2001. Ann Rheum Dis. 2005;64(10):1431-5. Epub 2005 Apr 7

Guillemin F, Saraux A, Guggenbuhl P, Roux CH, Fardellone P, Le Bihan E, Cantagrel A, Chary-Valckenaere I, Euller-Ziegler L, Flipo RM, Juvin R, Behier JM, Fautrel B, Masson C, Coste J. Prevalence of rheumatoid arthritis in France: 2001. Ann Rheum Dis. 2005;64(10):1427-30. Epub 2005 Mar 30

Ganry O, Baudoin C, Fardellone P, Peng J, Raverdy N. Bone mass density and risk of breast cancer and survival in older women. Eur J Epidemiol. 2004;19(8):785-92

Jouen F, Vittecoq O, Leguillou F, Tabti-Titon I, Menard JF, Mejjad O, Pouplin S, Boumier P, Fardellone P, Gayet A, Gilbert D, Tron F, Le Loët X. Diagnostic and prognostic values of anti glucose-6-phosphate isomerase antibodies in community-recruited patients with very early arthritis. Clin Exp Immunol. 2004;137(3):606-11

Herlidou S, Grebe R, Grados F, Leuyer N, Fardellone P, Meyer ME. Influence of age and osteoporosis on calcaneus trabecular bone structure: a preliminary in vivo MRI study by quantitative texture analysis. Magn Reson Imaging. 2004 ;22(2):237-43.

Ganry O, Tramier B, Fardellone P, Raverdy N, Dubreuil A. High bone-mass density as a marker for breast cancer in post-menopausal women. Breast. 2001 ;10(4):313-7

Grados F, Marcelli C, Dargent-Molina P, Roux C, Vergnol JF, Meunier PJ, Fardellone P. Prevalence of vertebral fractures in French women older than 75 years from the EPIDOS study.Bone. 2004 ;34(2):362-7

Saraux A, Guillemin F, Fardellone P, Guggenbuhl P, Behier JM, Cantagrel A, Euller-Ziegler L, Flipo RM, Juvin R, Le Loet X, Masson C, Sany J, Schaeverbeke T, Coste J; Epidemiology Section, French Society for Rheumatology. Agreement between rheumatologist visit and lay interviewer telephone survey for screening for rheumatoid arthritis and spondyloarthropathy.Joint Bone Spine. 2004 ;71(1):44-50

Lefauveau P, Fardellone P. Extraskeletal risk factors for fractures of the proximal femur. Joint Bone Spine. 2004;71(1):14-7

Maraval A, Grados F, Royant V, Damade R, Boulu G, Fardellone P. Longitudinal femoral shaft due to bone insufficiency. A review of three cases. Joint Bone Spine. 2003;70(6):526-31.

Vittecoq O, Incaurgarat B, Jouen-Beades F, Legoedec J, Letourneur O, Rolland D, Gervasi G, Menard JF, Gayet A, Fardellone P, Daragon A, Jolivet M, le Loet X, Tron F. Autoantibodies recognizing citrullinated rat filaggrin in an ELISA using citrullinated and non-citrullinated recombinant proteins as antigens are highly diagnostic for rheumatoid arthritis. Clin Exp Immunol. 2004;135(1):173-80.

Deprez X, Fardellone P. Nonpharmacological prevention of osteoporotic fractures. Joint Bone Spine. 2003;70(6):448-57.

Harrington JT, Ste-Marie LG, Brandi ML, Civitelli R, Fardellone P, Grauer A, Barton I, Boonen S. Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis. Calcif Tissue Int. 2004;74(2):129-35

Grados F, Brazier M, Kamel S, Mathieu M, Hurtebize N, Maamer M, Garabedian M, Sebert JL, Fardellone P.
Prediction of bone mass density variation by bone remodeling markers in postmenopausal women with vitamin D insufficiency treated with calcium and vitamin D supplementation. J Clin Endocrinol Metab. 2003;88(11):5175-9

Guillemin F, Saraux A, Fardellone P, Guggenbuhl P, Behier JM, Coste J; Epidemiology Committe of the French Society of Reumatology. Detection of cases of inflammatory rheumatic disorders: performance of a telephone questionnaire designed for use by patient interviewers. Ann Rheum Dis. 2003 ;62(10):957-63

Grados F, Brazier M, Kamel S, Duver S, Heurtebize N, Maamer M, Mathieu M, Garabedian M, Sebert JL, Fardellone P. Effects on bone mineral density of calcium and vitamin D supplementation in elderly women with vitamin D deficiency. Joint Bone Spine. 2003 ;70(3):203-8.

Grados F, Roux C, de Vernejoul MC, Utard G, Sebert JL, Fardellone P. Comparison of four morphometric definitions and a semiquantitative consensus reading for assessing prevalent vertebral fractures. Osteoporos Int. 2001;12(9):716-22.

Vittecoq O, Salle V, Jouen-Beades F, Krzanowska K, Menard JF, Gayet A, Fardellone P, Tauveron P, Le Loet X, Tron F. Autoantibodies to the 27 C-terminal amino acids of calpastatin are detected in a restricted set of connective tissue diseases and may be useful for diagnosis of rheumatoid arthritis in community cases of very early arthritis. Rheumatology (Oxford). 2001;40(10):1126-34.

Ganry O, Baudoin C, Fardellone P, Dubreuil A. Alcohol consumption by non-institutionalised elderly women: the EPIDOS Study. Public Health. 2001;115(3):186-91

Grados F, Depriester C, Cayrolle G, Hardy N, Deramond H, Fardellone P. Long-term observations of vertebral osteoporotic fractures treated by percutaneous vertebroplasty. Rheumatology (Oxford). 2000;39(12):1410-4

Westeel FP, Mazouz H, Ezaitouni F, Hottelart C, Ivan C, Fardellone P, Brazier M, El Esper I, Petit J, Achard JM, Pruna A, Fournier A. Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation. Kidney Int. 2000;58(4):1788-96

Ganry O, Baudoin C, Fardellone P. Effect of alcohol intake on bone mineral density in elderly women: The EPIDOS Study. Epidemiologie de l'Osteoporose. Am J Epidemiol. 2000 15;151(8):773-80

Lecuyer N, Grados F, Dargent-Molina P, Deramond H, Meunier PJ, Fardellone P. Prevalence of Paget's disease of bone and spinal hemangioma in French women older than 75 years: data from the EPIDOS study. Joint Bone Spine. 2000;67(4):315-8

Delmas PD, Confavreux E, Garnero P, Fardellone P, de Vernejoul MC, Cormier C, Arce JC. A combination of low doses of 17 beta-estradiol and norethisterone acetate prevents bone loss and normalizes bone turnover in postmenopausal women. Osteoporos Int. 2000;11(2):177-87.

Grados F, Fardellone P, Benammar M, Muller C, Roux C, Sebert JL. Influence of age and sex on vertebral shape indices assessed by radiographic morphometry. Osteoporos Int. 1999;10(6):450-5

Ghazali A, Fardellone P, Pruna A, Atik A, Achard JM, Oprisiu R, Brazier M, Remond A, Moriniere P, Garabedian M, Eastwood J, Fournier A. Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol? Kidney Int. 1999;55(6):2169-77.

Fournier A, Fardellone P, Achard JM, Ghazali A, Pruna A, El Esper N, Moriniere P. Importance of vitamin D repletion in uraemia. Nephrol Dial Transplant. 1999;14(4):819-23

Clavel G, Grados F, Cayrolle G, Bellony R, Leduc I, Lafont B, Ducroix JP, Fardellone P. Polyarthritis following intravesical BCG immunotherapy. Report of a case and review of 26 cases in the literature. Rev Rhum Engl Ed. 1999;66(2):115-8

Ezaitouni F, Westeel PF, Fardellone P, Mazouz H, Brazier M, el Esper I, Sebert JL, Petit J, Westeel A, Pruna A, Fournier A. [Long-term stability of bone mineral density in patients with renal transplant treated with cyclosporine and low doses of corticoids. Protective role of cyclosporine?] Presse Med. 1998 18;27(15):705-12

Bataille P, Fardellone P, Ghazali A, Cayrolle G, Hottelart C, Achard JM, Fournier A. Pathophysiology and treatment of idiopathic hypercalciuria. Curr Opin Rheumatol. 1998;10(4):373-88

Kamel S, Fardellone P, Meddah B, Lorget-Gondelmann F, Sebert JL, Brazier M. Response of several markers of bone collagen degradation to calcium supplementation in postmenopausal women with low calcium intake. Clin Chem. 1998;44(7):1437-42

Fardellone P, Brazier M, Kamel S, Gueris J, Graulet AM, Lienard J, Sebert JL. Biochemical effects of calcium supplementation in postmenopausal women: influence of dietary calcium intake. Am J Clin Nutr. 1998;67(6):1273-8

Guezennec CY, Chalabi H, Bernard J, Fardellone P, Krentowski R, Zerath E, Meunier PJ. Is there a relationship between physical activity and dietary calcium intake? A survey in 10,373 young French subjects. Med Sci Sports Exerc. 1998;30(5):732-9

Grados F, Houvenagel E, Cayrolle G, Bellony R, Fardellone P, Sebert JL. Two new cancer locations accompanied with palmar fasciitis and polyarthritis. Rev Rhum Engl Ed. 1998;65(3):212-4

Sebert JL, Fardellone P, Maamer M, Agbomson F, Brazier M, Garabedian M. Follow-up study of biological parameters in elderly institutionalized patients more than one year after discontinuation of calcium-vitamin D supplementation. Rev Rhum Engl Ed. 1996;63(7-8):498-501

Dernière mise à jour : 17-01-2017